Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.
Gu T, Tian X, Wang Y, Yang W, Li W, Song M, Zhao R, Wang M, Gao Q, Li T, Zhang C, Kundu JK, Liu K, Dong Z, Lee MH.
Gu T, et al. Among authors: li t, li w.
Front Immunol. 2023 May 2;14:1145028. doi: 10.3389/fimmu.2023.1145028. eCollection 2023.
Front Immunol. 2023.
PMID: 37205112
Free PMC article.